Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2016 Mar 15;25(5):791–798. doi: 10.1158/1055-9965.EPI-15-1019

Table 4.

Adjusted geometric mean concentration of plasma hormones by AHEI (not including alcohol) dietary pattern score quartiles among up to 1,990 premenopausal women in the Nurses’ Health Study II

AHEI score p-value
trend,
median of
Qs
Percent differenceb and
95% CI
Hormone N Q1 Q2 Q3 Q4
Range (21.5–40.2) (40.3–46.2) (46.2–53.2) (53.2–81.1)
Follicular Estradiol (pg/mL) 1,397 75.3 60.9 66.5 64.6 0.05 −14.2% (−24.6%, −2.4%)
Luteal Estradiol (pg/mL) 1,524 156 159 150 146 0.04 −6.7% (−14.3%, 1.5%)
Follicular Free Estradiol 1,361 0.78 0.69 0.69 0.71 0.10 −9.2% (−18.2%, 0.8%)
Luteal Free Estradiol 1,508 1.92 1.98 1.89 1.75 0.01 −9.3% (−16.8%, −1.1%)
Follicular Estrone (pg/mL) 1,417 49.9 45.6 46.4 45.4 0.04 −9.1%(−16.1%, −1.4%)
Luteal Estrone (pg/mL) 1,571 91.7 94.5 91.7 84.9 0.01 −7.5% (−13.6%, −0.9%)
Follicular estrone sulfate (pg/mL) 444 814 847 860 765 0.43 −6.0%(−22.2%, 13.6%)
Luteal estrone sulfate (pg/mL) 449 1,577 1,690 1,584 1,468 0.36 −6.9% (−24.3%, 14.5%)
Luteal Progesterone (ng/dL) 1,587 1,189 1,197 1,233 1,225 0.45 3.0% (−5.9%, 12.8%)
  DHEA (ng/dL)c 386 854 848 864 807 0.46 −5.5%(−17.8%, 8.7%)
  DHEAS (µg/dL)c 1,083 123 127 129 121 0.78 −1.6% (−11.0%, 8.8%)
Testosterone (ng/dL)d 1,956 23.7 24.5 24.3 22.8 0.11 −3.7%(−8.5%, 1.3%)
Free testosterone (ng/dL)d 1,898 0.19 0.20 0.20 0.18 0.09 −6.0% (−12.4%, 0.9%)
Androstenedione (ng/dL)d 626 130 134 129 120 0.03 −7.8%(−15.4%, 0.4%)
Prolactin (ng/dL)d 1,300 21.8 20.6 22.0 21.9 0.60 0.5% (−9.9%, 12.1%)
SHBG (nmol/L)d 1,675 71.9 68.8 70.6 71.9 0.73 −0.04% (−6.5%, 6.9%)
a

All geometric mean concentrations are adjusted for age at blood collection (continuous), BMI at blood collection (<22.5, 22.5 to <25, 25 to <27.5, 27.5 to <30, 30+), total kilocalories (continuous), smoking (never smoker, past smoker with >= 5 years since quitting, past smoker with <5 years since quitting, current smoker of <15 cigarettes per day, current smoker of 15+ cigarettes per day), alcohol use (non-drinker, <=10g/day, 10.1–20 g/day, >20 g/day) duration of past oral contraceptive use (never, <4 years, 4+ years), age at first birth/parity (nulliparous, 1–2 children and age at first birth < 25 years, 1–2 children and age at first birth > 25 years, >3 children and age at first birth < 25 years, >3 children and age at first birth > 25 years), age at menarche (<12, 12–13, >13 years), physical activity in MET-hours/week (<3, 3 to <9, 9 to <18, 18 to <27, 27+), date of blood collection (month/year, <1/97, 2/97–1/98, 2/98–1/99, >2/99), time of day of blood collection (1–8 a.m.,9 a.m. to noon, 1–4 p.m., 5 p.m. to midnight), and fasting status (<10, >10 hours). Models that included luteal or average of timed samples also were adjusted for the difference between luteal blood draw date and date of next menstrual period (3–7, 8–12,13–17, 18–21 days, unknown/untimed).

b

Percent difference between Q4 vs. Q1

c

Luteal/untimed

d

Average of follicular and luteal measures, or untimed